Biomimetic Innovations Enters Agreement with Sanara MedTech

Biomimetic Innovations Enters Agreement with Sanara MedTech

Biomimetic Innovations (BMI) executed an exclusive license and distribution agreement with Sanara MedTech. In tandem, Sanara agreed to make a minority investment in cash for equity in BMI.

Sanara acquired exclusive U.S. marketing, sales, and distribution rights to OsStic Synthetic Injectable Structural Bio-Adhesive Bone Void Filler and a...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0